Skip to content
Important: This site presents data from the FDA Adverse Event Reporting System (FAERS). A report does not mean the drug caused the event. Full disclaimer.

FOSAPREPITANT: 487 Adverse Event Reports & Safety Profile

Grow Your Own Natural Pharmacy at Home

Medicinal Garden Kit — 10 healing herbs, 4,818 seeds + step-by-step guide.

Get the Kit
487
Total FAERS Reports
154 (31.6%)
Deaths Reported
264
Hospitalizations
487
As Primary/Secondary Suspect
166
Life-Threatening
197
Disabilities

First Report: 20131028 · Latest Report: 20250923

What Are the Most Common FOSAPREPITANT Side Effects?

#1 Most Reported
Dyspnoea
195 reports (40.0%)
#2 Most Reported
Infusion related reaction
167 reports (34.3%)
#3 Most Reported
Hypersensitivity
157 reports (32.2%)

All FOSAPREPITANT Side Effects by Frequency

Side Effect Reports % of Total Deaths Hosp.
Dyspnoea 195 40.0% 83 143
Infusion related reaction 167 34.3% 64 130
Hypersensitivity 157 32.2% 81 148
Duodenal ulcer perforation 155 31.8% 92 155
Confusional state 149 30.6% 85 149
Glossodynia 149 30.6% 86 149
Folliculitis 146 30.0% 83 146
Arthralgia 144 29.6% 79 143
Blister 144 29.6% 81 144
Discomfort 144 29.6% 80 143
Helicobacter infection 144 29.6% 81 144
Hepatic enzyme increased 144 29.6% 81 144
Alopecia 143 29.4% 79 143
Arthropathy 143 29.4% 80 143
Fatigue 143 29.4% 78 141
Abdominal discomfort 141 29.0% 75 139
Contusion 141 29.0% 78 141
Hand deformity 139 28.5% 76 139
Impaired healing 138 28.3% 75 138
Anti-cyclic citrullinated peptide antibody positive 137 28.1% 74 137

Who Reports FOSAPREPITANT Side Effects? Age & Gender Data

Gender: 83.0% female, 17.0% male. Average age: 49.6 years. Most reports from: CA. View detailed demographics →

Is FOSAPREPITANT Getting Safer? Reports by Year

YearReportsDeathsHosp.
2013 1 1 0
2014 5 0 4
2015 9 0 4
2016 13 0 6
2017 10 0 3
2018 13 1 7
2019 13 0 2
2020 11 5 2
2021 30 5 6
2022 37 1 3
2023 38 0 3
2024 7 0 1
2025 21 1 3

View full timeline →

What Is FOSAPREPITANT Used For?

IndicationReports
Rheumatoid arthritis 117
Product used for unknown indication 110
Prophylaxis of nausea and vomiting 82
Nausea 22
Breast cancer 18
Vomiting 17
Premedication 16
Chemotherapy side effect prophylaxis 14
Antiemetic supportive care 12
Chemotherapy 6

FOSAPREPITANT vs Alternatives: Which Is Safer?

FOSAPREPITANT vs FOSAPREPITANT DIMEGLUMINE FOSAPREPITANT vs FOSCARBIDOPA\FOSLEVODOPA FOSAPREPITANT vs FOSCARNET FOSAPREPITANT vs FOSFOMYCIN FOSAPREPITANT vs FOSFOMYCIN TROMETHAMINE FOSAPREPITANT vs FOSINOPRIL FOSAPREPITANT vs FOSPHENYTOIN FOSAPREPITANT vs FOSTAMATINIB FOSAPREPITANT vs FOSTEMSAVIR TROMETHAMINE FOSAPREPITANT vs FOTEMUSTINE

Official FDA Label for FOSAPREPITANT

Official prescribing information from the FDA-approved drug label.